Ausper Biopharma Co., Ltd.
Clinical trials sponsored by Ausper Biopharma Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot aims to free hepatitis b patients from daily pills Results expected Dec 2026 (estimated)
- New shot aims to cure hepatitis b without daily pills Results expected Dec 2026 (estimated)
- New injection aims to suppress hepatitis b virus Results expected Jun 2027 (estimated)
- New combo aims to cure hepatitis b without lifelong pills Results expected Jul 2027 (estimated)
- New shot aims to silence hepatitis b virus Results expected Jul 2027 (estimated)
-
New shot aims to silence hepatitis b virus
Disease control OngoingThis study tests an injection called AHB-137 in 20 adults with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if the drug can lower or eliminate hepatitis B surface antigen (HBsAg) and viral DNA, potentially leading to a functional cure. Parti…
Phase 2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug aims to cure chronic hepatitis b in landmark trial
Disease control OngoingThis Phase 2 trial tests an experimental drug called AHB-137 in 105 adults with chronic hepatitis B who have not been treated before. The goal is to see if the drug can clear the hepatitis B surface antigen and lower the virus to undetectable levels, potentially leading to a func…
Phase 2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New shot aims to cure hepatitis b without daily pills
Disease control OngoingThis phase 3 trial tests an experimental drug called AHB-137 in 577 adults with HBeAg-negative chronic hepatitis B who are already on standard antiviral pills. Participants receive weekly injections of AHB-137 or a placebo for a set period, then stop all hepatitis B treatment. Th…
Phase 3 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC